{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T22:58:03Z","timestamp":1768690683481,"version":"3.49.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.expneurol.2015.04.020","type":"journal-article","created":{"date-parts":[[2015,5,6]],"date-time":"2015-05-06T01:03:56Z","timestamp":1430874236000},"page":"36-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy"],"prefix":"10.1016","volume":"271","author":[{"given":"Frank","family":"Matthes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claes","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Stein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6025-2427","authenticated-orcid":false,"given":"Carl","family":"Eistrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Fogh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volkmar","family":"Gieselmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Wenger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Matzner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2015.04.020_bb0005","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.ymgme.2011.12.012","article-title":"Mannose-6-phosphate pathway: a review on its role in lysosomal function and dysfunction","volume":"105","author":"Coutinho","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0010","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/(SICI)1098-1004(1999)14:3<256::AID-HUMU9>3.0.CO;2-6","article-title":"Molecular basis of late-life globoid cell leukodystrophy","volume":"14","author":"De Gasperi","year":"1999","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0015","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1146\/annurev-genom-090711-163739","article-title":"Enzyme replacement therapy for lysosomal diseases: lessons from 20years of experience and remaining challenges","volume":"13","author":"Desnick","year":"2012","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0020","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1093\/brain\/103.3.695","article-title":"Hereditary leucodystrophy in the mouse: the new mutant twitcher","volume":"103","author":"Duchen","year":"1980","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2015.04.020_bb0025","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/GIM.0b013e3181a16e04","article-title":"The long-term outcomes of presymptomatic infants transplanted for Krabbe disease: report of the workshop held on July 11 and 12, 2008, Holiday Valley, New York","volume":"11","author":"Duffner","year":"2009","journal-title":"Genet. Med."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0030","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1056\/NEJMoa042604","article-title":"Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease","volume":"352","author":"Escolar","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0035","first-page":"375","article-title":"Animal model: globoid cell leukodystrophy in the dog","volume":"66","author":"Fletcher","year":"1972","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0040","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/jcp.21070","article-title":"Psychosine-induced apoptosis and cytokine activation in immune peripheral cells of Krabbe patients","volume":"212","author":"Formichi","year":"2007","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0045","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s004390050532","article-title":"Adult onset globoid cell leukodystrophy (Krabbe disease): analysis of galactosylceramidase cDNA from four Japanese patients","volume":"100","author":"Furuya","year":"1997","journal-title":"Hum. Genet."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0050","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0009-8981(77)90401-6","article-title":"A practical chromogenic procedure for the diagnosis of Krabbe's disease","volume":"16","author":"Gal","year":"1977","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.expneurol.2015.04.020_bb0055","doi-asserted-by":"publisher","first-page":"R54","DOI":"10.1093\/hmg\/ddr112","article-title":"Combination therapies for lysosomal storage disease: is the whole greater than the sum of its parts?","volume":"20","author":"Hawkins-Salsbury","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0060","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.gene.2013.11.003","article-title":"Late-onset Krabbe disease is predominant in Japan and its mutant precursor protein undergoes more effective processing than the infantile-onset form","volume":"534","author":"Hossain","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.expneurol.2015.04.020_bb0065","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/0006-8993(80)90159-6","article-title":"The twitcher mouse: an enzymatically authentic model of human globoid cell leukodystrophy (Krabbe disease)","volume":"202","author":"Kobayashi","year":"1980","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0070","first-page":"227","article-title":"Expression of glial fibrillary acidic protein in the CNS and PNS of murine globoid cell leukodystrophy, the twitcher","volume":"125","author":"Kobayashi","year":"1986","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0075","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1096\/fj.05-3826fje","article-title":"Enzyme replacement therapy results in substantial improvements in early clinical phenotype in a mouse model of globoid cell leukodystrophy","volume":"19","author":"Lee","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0080","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.nbd.2006.03.005","article-title":"Suppression of galactosylceramidase (GALC) expression in the twitcher mouse model of globoid cell leukodystrophy (GLD) is caused by nonsense-mediated mRNA decay (NMD)","volume":"23","author":"Lee","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0085","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.pediatrneurol.2014.08.003","article-title":"Experimental therapies in the murine model of globoid cell leukodystrophy","volume":"51","author":"Li","year":"2014","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0090","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/ana.410400119","article-title":"Multiple mutations in the GALC gene in a patient with adult-onset Krabbe disease","volume":"40","author":"Luzi","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0095","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1006\/geno.1997.4744","article-title":"Characterization of the rhesus monkey galactocerebrosidase (GALC) cDNA and gene and identification of the mutation causing globoid cell leukodystrophy (Krabbe disease) in this primate","volume":"42","author":"Luzi","year":"1997","journal-title":"Genomics"},{"key":"10.1016\/j.expneurol.2015.04.020_bb0100","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1006\/mgme.2001.3194","article-title":"Generation of a mouse with low galactocerebrosidase activity by gene targeting: a new model of globoid cell leukodystrophy (Krabbe disease)","volume":"73","author":"Luzi","year":"2001","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0105","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.brainres.2009.09.017","article-title":"Effects of treatments on inflammatory and apoptotic markers in the CNS of mice with globoid cell leukodystrophy","volume":"1300","author":"Luzi","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0110","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1093\/hmg\/dds086","article-title":"Efficacy of enzyme replacement therapy in an aggravated mouse model of metachromatic leukodystrophy declines with age","volume":"21","author":"Matthes","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0115","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00109-008-0309-3","article-title":"Non-inhibitory antibodies impede lysosomal storage reduction during enzyme replacement therapy of a lysosomal storage disease","volume":"86","author":"Matzner","year":"2008","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0120","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/BF00965887","article-title":"Disorders in myelination in the twitcher mutant: immunohistochemical and biochemical studies","volume":"10","author":"Mikoshiba","year":"1985","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0125","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0009-8981(98)00095-3","article-title":"Expression and processing of recombinant human galactosylceramidase","volume":"276","author":"Nagano","year":"1998","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.expneurol.2015.04.020_bb0130","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/j.1471-4159.1973.tb07519.x","article-title":"Myelination in rat brain: method of myelin isolation","volume":"21","author":"Norton","year":"1973","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0135","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0166-4328(87)90007-6","article-title":"Neurological and neurobehavioral development of the mutant \u2018twitcher\u2019 mouse","volume":"25","author":"Olmstead","year":"1987","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0140","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ymgme.2012.05.021","article-title":"Bone marrow transplantation increases efficacy of central nervous system-directed enzyme replacement therapy in the murine model of globoid cell leukodystrophy","volume":"107","author":"Qin","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0145","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.ymthe.2004.12.020","article-title":"AAV-mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophy","volume":"11","author":"Rafi","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0150","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1038\/mt.2012.153","article-title":"Extended normal life after AAVrh10-mediated gene therapy in the mouse model of Krabbe disease","volume":"20","author":"Rafi","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0155","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ymgme.2014.12.300","article-title":"Intravenous injection of AAVrh10-GALC after the neonatal period in twitcher mice results in significant expression in the central and peripheral nervous systems and improvement of clinical features","volume":"114","author":"Rafi","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0160","doi-asserted-by":"publisher","first-page":"9945","DOI":"10.1523\/JNEUROSCI.1802-11.2011","article-title":"Bone marrow transplantation augments the effect of brain- and spinal cord-directed adeno-associated virus 2\/5 gene therapy by altering inflammation in the murine model of globoid-cell leukodystrophy","volume":"31","author":"Reddy","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0165","doi-asserted-by":"publisher","first-page":"e64647","DOI":"10.1371\/journal.pone.0064647","article-title":"Central nervous system pathology progresses independently of KC and CXCR2 in globoid-cell leukodystrophy","volume":"8","author":"Reddy","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2015.04.020_bb0170","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/stem.555","article-title":"Mesenchymal lineage stem cells have pronounced anti-inflammatory effects in the twitcher mouse model of Krabbe's disease","volume":"29","author":"Ripoll","year":"2011","journal-title":"Stem Cells"},{"key":"10.1016\/j.expneurol.2015.04.020_bb0175","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1046\/j.1471-4159.1996.66031118.x","article-title":"Molecular cloning and expression of cDNA for murine galactocerebrosidase and mutation analysis of the twitcher mouse, a model of Krabbe's disease","volume":"66","author":"Sakai","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0180","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/gene.1076","article-title":"Efficient FLP recombination in mouse ES cells and oocytes","volume":"31","author":"Schaft","year":"2001","journal-title":"Genesis"},{"key":"10.1016\/j.expneurol.2015.04.020_bb0185","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.ajpath.2013.10.011","article-title":"Innate immune activation in the pathogenesis of a murine model of globoid cell leukodystrophy","volume":"184","author":"Snook","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0190","doi-asserted-by":"publisher","first-page":"e57560","DOI":"10.1371\/journal.pone.0057560","article-title":"Substrate compositional variation with tissue\/region and Gba1 mutations in mouse models\u2014implications for Gaucher disease","volume":"8","author":"Sun","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2015.04.020_bb0195","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1177\/08830738030180090201","article-title":"Globoid cell leukodystrophy (Krabbe's disease): update","volume":"18","author":"Suzuki","year":"2003","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0200","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1750-3639.1995.tb00601.x","article-title":"The twitcher mouse: a model for Krabbe disease and for experimental therapies","volume":"5","author":"Suzuki","year":"1995","journal-title":"Brain Pathol."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0205","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/BF00293398","article-title":"Spatio-temporal progression of demyelination in twitcher mouse: with clinico-pathological correlation","volume":"88","author":"Taniike","year":"1994","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0210","series-title":"GeneReviews\u2122","article-title":"Krabbe disease","author":"Wenger","year":"2000"},{"key":"10.1016\/j.expneurol.2015.04.020_bb0215","series-title":"Techniques in Diagnostic Human Biochemical Genetics","first-page":"587","article-title":"Screening for lysosomal disorders","author":"Wenger","year":"1991"},{"key":"10.1016\/j.expneurol.2015.04.020_bb0220","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/(SICI)1098-1004(1997)10:4<268::AID-HUMU2>3.0.CO;2-D","article-title":"Molecular genetics of Krabbe disease (globoid cell leukodystrophy): diagnostic and clinical implications","volume":"10","author":"Wenger","year":"1997","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0225","series-title":"Scriver's Online Metabolic and Molecular Bases of Inherited Disease","article-title":"Krabbe disease (globoid cell leukodystrophy)","author":"Wenger","year":"2013"},{"key":"10.1016\/j.expneurol.2015.04.020_bb0230","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ymgme.2013.12.009","article-title":"Krabbe disease: are certain mutations disease-causing only when specific polymorphisms are present or when inherited in trans with specific second mutations?","volume":"111","author":"Wenger","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0235","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/S0022-2275(20)31539-X","article-title":"Quantification of galactosylsphingosine in the twitcher mouse using electrospray ionization\u2013tandem mass spectrometry","volume":"42","author":"Whitfield","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.expneurol.2015.04.020_bb0240","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1093\/jnen\/60.11.1062","article-title":"Expression of immune-related molecules is downregulated in twitcher mice following bone marrow transplantation","volume":"60","author":"Wu","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488615001430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488615001430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T07:41:43Z","timestamp":1651909303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488615001430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":48,"alternative-id":["S0014488615001430"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2015.04.020","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2015.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}